Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GPTBots.ai is an enterprise-grade, no-code AI agent development platform designed to facilitate the creation and deployment of intelligent automation tools across various industries, including healthcare and life sciences. As a subsidiary of Aurora Mobile (NASDAQ: JG), the platform leverages advanced large language models (LLMs) such as GPT-4 and GPT-5 to enable non-technical users to build sophisticated AI agents for customer support, data analysis, and workflow automation. In the healthcare sector, GPTBots.ai provides specialized solutions for patient triage, appointment scheduling, and clinical documentation, ensuring compliance with data privacy standards like HIPAA and GDPR. The platform's core technology includes Retrieval-Augmented Generation (RAG) and multi-model integration, allowing organizations to ground AI responses in proprietary knowledge bases. By streamlining routine administrative and clinical tasks, GPTBots.ai aims to improve operational efficiency and patient engagement for healthcare providers and pharmaceutical enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GPTBots.ai.